West Pharmaceutical Services (WST) Receivables - Net (2009 - 2026)

West Pharmaceutical Services' Receivables - Net history runs 18 years deep, the most recent figure standing at $685.6 million for Q1 2026.

• In Q1 2026, Receivables - Net rose 26.12% year-over-year to $685.6 million; the TTM figure through Mar 2026 stood at $685.6 million (up 26.12% YoY), while the FY2025 annual figure was $574.4 million, up 3.96% from the prior year.
• Receivables - Net came in at $685.6 million for Q1 2026 at West Pharmaceutical Services, up from $574.4 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $685.6 million in Q1 2026 to a low of $479.4 million in Q2 2024.
• A 5-year average of $540.6 million and a median of $524.3 million in 2024 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net declined 10.29% in 2024 and grew 26.12% in 2026, its largest moves.
• West Pharmaceutical Services' Receivables - Net stood at $507.4 million in 2022, then increased by 0.91% to $512.0 million in 2023, then increased by 7.91% to $552.5 million in 2024, then gained by 3.96% to $574.4 million in 2025, then increased by 19.36% to $685.6 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $685.6 million, $574.4 million, and $625.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison